Ethical Compliance
GLENMARK PHARMACEUTICALS
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0%
Debt
6.9%
Liquidity
11.6%
Revenue
Debt
Liquidity
0%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Services | ₹128.68 |
| Other Operating Revenue | ₹177.64 |
| Other Income | ₹833.82 |
| Sale of Products - Pharma | ₹11,506.78 |
Questionable
INR Crores
| Dividend Income | ₹0.00 |
Non Compliant
INR Crores
| Interest Income | ₹6.18 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹6.18 |
| Total: | ₹6.18 |
| Total Revenue: | ₹12,653.09 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹6.18
₹12,653.09
= 0%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
